Skip to main content
Top
Published in: Advances in Therapy 7/2020

Open Access 01-07-2020 | Acute Coronary Syndrome | Original Research

Troponin Levels Relate to CRP Concentrations in Patients With NAFLD on Maintenance Haemodialysis: A Retrospective Study

Authors: Domenico Capone, Mauro Vinciguerra, Annalisa Ragosta, Vincenzo Citro, Giovanni Tarantino

Published in: Advances in Therapy | Issue 7/2020

Login to get access

Abstract

Introduction

Several studies have shown that high sensitivity cardiac troponin (hs-cTnT) levels are elevated in patients suffering from end-stage renal disease (ESRD), even in the absence of clinical signs and instrumental features of symptomatic acute coronary syndrome (ACS). In patients undergoing haemodialysis because of ESRD, nephrologists bear witness to this increase, whose origin and clinical impact are not yet well defined.

Methods

By a retrospective study, we evaluated data from records of 70 patients with ESRD on haemodialysis, all of them with a history of NAFLD, not suffering for at least 3 months from symptomatic angina and without a history of ischemic heart disease in the same period.

Results

Hs-cTnT and C-reactive protein (CRP) levels both increased and were correlated, rho = 0.34, P = 0.004. The correlation coefficient between troponin and age was significant, rho = 0.47, P = 0.0001. Serum concentrations of hs-cTnT for the whole population were positively predicted by CRP levels, P = 0.004. On separation of the population by gender, significant correlation between hs-cTnT and CRP was not found in women and was only present in men, P = 0.66 and P = 0.000, respectively.

Discussion

The assessment of hs-cTnT levels could represent a biological marker in particular subgroups of haemodialysis patients, especially for male patients with higher CRP, those at greater risk of silent myocardial ischemia and future major adverse cardiac events.

Conclusions

The evaluation of hs-cTnT in haemodialysed patients with NAFLD could indicate that men with higher CRP should undergo close monitoring in order to adopt specific therapy.
Literature
1.
go back to reference Dawwas GK, Liu X, Nguyen MH. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study. J Intern Med. 2019;286:711–22.CrossRefPubMedPubMedCentral Dawwas GK, Liu X, Nguyen MH. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study. J Intern Med. 2019;286:711–22.CrossRefPubMedPubMedCentral
2.
go back to reference Wu S, Wu F, Ding Y, Hou J, Bi J, Zhang Z. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis. Sci Rep. 2016;6:33386.CrossRefPubMedPubMedCentral Wu S, Wu F, Ding Y, Hou J, Bi J, Zhang Z. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis. Sci Rep. 2016;6:33386.CrossRefPubMedPubMedCentral
3.
go back to reference Chinnadurai R, Ritchie J, Green D, Kalra PA. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease. Nephrol Dial Transplant. 2019;34:449–57.CrossRefPubMed Chinnadurai R, Ritchie J, Green D, Kalra PA. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease. Nephrol Dial Transplant. 2019;34:449–57.CrossRefPubMed
4.
go back to reference Mikolasevic I, Racki S, Zaputovic L, Lukenda V, Sladoje-Martinovic B, Orlic L. Nonalcoholic fatty liver disease (NAFLD) and cardiovascular risk in renal transplant recipients. Kidney Blood Press Res. 2014;39:308–14.CrossRefPubMed Mikolasevic I, Racki S, Zaputovic L, Lukenda V, Sladoje-Martinovic B, Orlic L. Nonalcoholic fatty liver disease (NAFLD) and cardiovascular risk in renal transplant recipients. Kidney Blood Press Res. 2014;39:308–14.CrossRefPubMed
5.
go back to reference de Filippi C, Wasserman S, Rosanio S, et al. Cardiac troponin T and C-reactive protein for predicting prognosis. Coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA. 2003;290:353–9.CrossRef de Filippi C, Wasserman S, Rosanio S, et al. Cardiac troponin T and C-reactive protein for predicting prognosis. Coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA. 2003;290:353–9.CrossRef
6.
go back to reference Michos ED, Wilson LM, Yeh HC, et al. Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome: a systematic review and meta-analysis. Ann Intern Med. 2014;161:491–501.CrossRefPubMed Michos ED, Wilson LM, Yeh HC, et al. Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome: a systematic review and meta-analysis. Ann Intern Med. 2014;161:491–501.CrossRefPubMed
7.
go back to reference Castini D, Persampieri S, Floreani R, et al. Troponin I levels in asymptomatic hemodialysis patients. Blood Purif. 2017;44:236–43.CrossRefPubMed Castini D, Persampieri S, Floreani R, et al. Troponin I levels in asymptomatic hemodialysis patients. Blood Purif. 2017;44:236–43.CrossRefPubMed
8.
go back to reference Fox WR, Diercks DB. Troponin assay use in the emergency department for management of patients with potential acute coronary syndrome: current use and future directions. Clin Exp Emerg Med. 2016;3:1–8.CrossRefPubMedPubMedCentral Fox WR, Diercks DB. Troponin assay use in the emergency department for management of patients with potential acute coronary syndrome: current use and future directions. Clin Exp Emerg Med. 2016;3:1–8.CrossRefPubMedPubMedCentral
10.
go back to reference Chen M, Gerson H, Eintracht S, Nessim SJ, MacNamara E. Effect of hemodialysis on levels of high-sensitivity cardiac troponin T. Am J Cardiol. 2017;120:2061–4.CrossRefPubMed Chen M, Gerson H, Eintracht S, Nessim SJ, MacNamara E. Effect of hemodialysis on levels of high-sensitivity cardiac troponin T. Am J Cardiol. 2017;120:2061–4.CrossRefPubMed
11.
go back to reference Narula AS, Jha V, Bali HK, Sakhuja V, Sapru RP. Cardiac arrhythmias and silent myocardial ischemia during hemodialysis. Ren Fail. 2000;22:355–68.CrossRefPubMed Narula AS, Jha V, Bali HK, Sakhuja V, Sapru RP. Cardiac arrhythmias and silent myocardial ischemia during hemodialysis. Ren Fail. 2000;22:355–68.CrossRefPubMed
12.
go back to reference McIntyre CW. Recurrent circulatory stress: the dark side of dialysis. Semin Dial. 2010;23:449–51.CrossRefPubMed McIntyre CW. Recurrent circulatory stress: the dark side of dialysis. Semin Dial. 2010;23:449–51.CrossRefPubMed
14.
go back to reference Bucharles SGE, Wallbach KKS, Moraes TP, Pecoits-Filho R. Hypertension in patients on dialysis: diagnosis, mechanisms, and management. J Bras Nefrol. 2019;4:400–11.CrossRef Bucharles SGE, Wallbach KKS, Moraes TP, Pecoits-Filho R. Hypertension in patients on dialysis: diagnosis, mechanisms, and management. J Bras Nefrol. 2019;4:400–11.CrossRef
15.
go back to reference Kjeldsen SE. Hypertension and cardiovascular risk: general aspects. Pharmacol Res. 2018;129:95–9.CrossRefPubMed Kjeldsen SE. Hypertension and cardiovascular risk: general aspects. Pharmacol Res. 2018;129:95–9.CrossRefPubMed
16.
go back to reference Zebrack JS, Anderson JL, Maycock CA, Horne BD, Bair TL, Muhlestein JB. Intermountain Heart Collaborative (IHC) Study. Group Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Am J Cardiol. 2002;89:145–9.CrossRefPubMed Zebrack JS, Anderson JL, Maycock CA, Horne BD, Bair TL, Muhlestein JB. Intermountain Heart Collaborative (IHC) Study. Group Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Am J Cardiol. 2002;89:145–9.CrossRefPubMed
17.
go back to reference Bagheri N, Taziki O, Falaknazi K. C-reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients. Saudi J Kidney Dis Transpl. 2009;20:789–93.PubMed Bagheri N, Taziki O, Falaknazi K. C-reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients. Saudi J Kidney Dis Transpl. 2009;20:789–93.PubMed
18.
go back to reference Heidari B. C-reactive protein and other markers of inflammation in hemodialysis patients. Caspian J Intern Med. 2013;4:611–6.PubMedPubMedCentral Heidari B. C-reactive protein and other markers of inflammation in hemodialysis patients. Caspian J Intern Med. 2013;4:611–6.PubMedPubMedCentral
19.
go back to reference de Lemos JA, Drazner MH, Omland T, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 2010;304:2503–12.CrossRefPubMedPubMedCentral de Lemos JA, Drazner MH, Omland T, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 2010;304:2503–12.CrossRefPubMedPubMedCentral
20.
go back to reference Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56:254–61.CrossRefPubMed Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56:254–61.CrossRefPubMed
21.
go back to reference Eda S, Kaufmann J, Roos W, Pohl S. Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal. 1998;12:137–44.CrossRefPubMedPubMedCentral Eda S, Kaufmann J, Roos W, Pohl S. Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal. 1998;12:137–44.CrossRefPubMedPubMedCentral
22.
go back to reference Ponikowski P, Voors AA, Anker SD, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;14:2129–200.CrossRef Ponikowski P, Voors AA, Anker SD, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;14:2129–200.CrossRef
23.
go back to reference Chen T, Hassan HC, Qian P, Vu M, Makris A. High-sensitivity troponin T and C-reactive protein have different prognostic values in hemo- and peritoneal dialysis populations: a cohort study. J Am Heart Assoc. 2018;7:e007876.PubMedPubMedCentral Chen T, Hassan HC, Qian P, Vu M, Makris A. High-sensitivity troponin T and C-reactive protein have different prognostic values in hemo- and peritoneal dialysis populations: a cohort study. J Am Heart Assoc. 2018;7:e007876.PubMedPubMedCentral
24.
go back to reference Yeniova AO, Küçükazman M, Ata N, et al. High-sensitivity C-reactive protein is a strong predictor of non-alcoholic fatty liver disease. Hepatogastroenterology. 2016;61:422–5. Yeniova AO, Küçükazman M, Ata N, et al. High-sensitivity C-reactive protein is a strong predictor of non-alcoholic fatty liver disease. Hepatogastroenterology. 2016;61:422–5.
26.
go back to reference Griffiths ME, Malan L, Delport R, Cockeran M, Reimann M. Troponin T release is associated with silent myocardial ischaemia in black men: the SABPA Study. Eur J Prev Cardiol. 2017;24:942–50.CrossRefPubMed Griffiths ME, Malan L, Delport R, Cockeran M, Reimann M. Troponin T release is associated with silent myocardial ischaemia in black men: the SABPA Study. Eur J Prev Cardiol. 2017;24:942–50.CrossRefPubMed
27.
go back to reference Wu PJ, Chen JB, Lee WC, et al. Oxidative stress and nonalcoholic fatty liver disease in hemodialysis patients. Biomed Res Int. 2018;1(2018):3961748. Wu PJ, Chen JB, Lee WC, et al. Oxidative stress and nonalcoholic fatty liver disease in hemodialysis patients. Biomed Res Int. 2018;1(2018):3961748.
28.
go back to reference Michos ED, Berger Z, Yeh HC, et al. Cardiac troponins used as diagnostic and prognostic tests in patients with kidney disease. Rockville: Agency for Healthcare Research and Quality (AHRQ). Comparative Effectiveness Review, No. 135; 2014. Michos ED, Berger Z, Yeh HC, et al. Cardiac troponins used as diagnostic and prognostic tests in patients with kidney disease. Rockville: Agency for Healthcare Research and Quality (AHRQ). Comparative Effectiveness Review, No. 135; 2014.
29.
go back to reference Myhre PL, O'Meara E, Claggett BL, et al. Cardiac troponin I and risk of cardiac events in patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2018;11:e005312.CrossRefPubMed Myhre PL, O'Meara E, Claggett BL, et al. Cardiac troponin I and risk of cardiac events in patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2018;11:e005312.CrossRefPubMed
30.
go back to reference Khan MH, Islam MN, Aditya GP, et al. Correlation of troponin-I level with left ventricular ejection fraction and in-hospital outcomes after first attack of non-ST segment elevation myocardial infarction. Mymensingh Med J. 2017;26:721–31.PubMed Khan MH, Islam MN, Aditya GP, et al. Correlation of troponin-I level with left ventricular ejection fraction and in-hospital outcomes after first attack of non-ST segment elevation myocardial infarction. Mymensingh Med J. 2017;26:721–31.PubMed
31.
go back to reference Hagström H, Nasr P, Ekstedt M, et al. Cardiovascular risk factors in non-alcoholic fatty liver disease. Liver Int. 2019;39(1):197–204.CrossRefPubMed Hagström H, Nasr P, Ekstedt M, et al. Cardiovascular risk factors in non-alcoholic fatty liver disease. Liver Int. 2019;39(1):197–204.CrossRefPubMed
32.
go back to reference Hellings WE, Pasterkamp G, Verhoeven BA, et al. Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy. J Vasc Surg. 2007;45:289–96.CrossRefPubMed Hellings WE, Pasterkamp G, Verhoeven BA, et al. Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy. J Vasc Surg. 2007;45:289–96.CrossRefPubMed
33.
go back to reference Zhang S-J, Wang Q, Cui Y-J, et al. High-sensitivity cardiac troponin T in geriatric patients. Arch Gerontol Geriatr. 2016;56:111–5.CrossRef Zhang S-J, Wang Q, Cui Y-J, et al. High-sensitivity cardiac troponin T in geriatric patients. Arch Gerontol Geriatr. 2016;56:111–5.CrossRef
34.
go back to reference Dubin RF, Li Y, He J, et al. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrol. 2013;14:229.CrossRefPubMedPubMedCentral Dubin RF, Li Y, He J, et al. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrol. 2013;14:229.CrossRefPubMedPubMedCentral
35.
go back to reference Forghani MS, Jadidoleslami MS, Naleini SN, Rajabnia M. Measurement of the serum levels of serum troponins I and T, albumin and C-reactive protein in chronic hemodialysis patients and their relationship with left ventricular hypertrophy and heart failure. Diabetes Metab Syndr. 2019;13:522–5.CrossRefPubMed Forghani MS, Jadidoleslami MS, Naleini SN, Rajabnia M. Measurement of the serum levels of serum troponins I and T, albumin and C-reactive protein in chronic hemodialysis patients and their relationship with left ventricular hypertrophy and heart failure. Diabetes Metab Syndr. 2019;13:522–5.CrossRefPubMed
36.
go back to reference Cohn PF. Silent ischemia: a timely aspect in coronary artery disease. Herz. 1987;12:314–7.PubMed Cohn PF. Silent ischemia: a timely aspect in coronary artery disease. Herz. 1987;12:314–7.PubMed
37.
go back to reference Kimura K, Tabei K, Asano Y, Hosoda S. Cardiac arrhythmias in hemodialysis patients. A study of incidence and contributory factors. Nephron. 1989;53:201–7.CrossRefPubMed Kimura K, Tabei K, Asano Y, Hosoda S. Cardiac arrhythmias in hemodialysis patients. A study of incidence and contributory factors. Nephron. 1989;53:201–7.CrossRefPubMed
38.
Metadata
Title
Troponin Levels Relate to CRP Concentrations in Patients With NAFLD on Maintenance Haemodialysis: A Retrospective Study
Authors
Domenico Capone
Mauro Vinciguerra
Annalisa Ragosta
Vincenzo Citro
Giovanni Tarantino
Publication date
01-07-2020
Publisher
Springer Healthcare
Published in
Advances in Therapy / Issue 7/2020
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-020-01385-z

Other articles of this Issue 7/2020

Advances in Therapy 7/2020 Go to the issue